| $552M | ||
| $193M | ||
| $154M | ||
| $83M | ||
| $68M | ||
| $68M |
Buys | $221,400 | 4 | 13 |
Sells | $5,311,677 | 28 | 87 |
| Saba Capital Management, L.P. | 10 percent owner | 2 | $195,880 | 28 | $5.31M | $-5.12M |
| DiMartino Rose | director | 1 | $15,530 | 0 | $0 | $15,530 |
| Maher Bill | director | 1 | $9,991 | 0 | $0 | $9,991 |
Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as market position for services or products, experience of business management, technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotech Index and the S&P 500 Index. It was formerly known as H&Q Life Sciences Investors fund. Tekla Life Sciences Investors was formed on February 20, 1992 and is domiciled in the United States.
Over the last 12 months, insiders at Tekla Life Sciences Investors have bought $221,400 and sold $5.31M worth of Tekla Life Sciences Investors stock.
On average, over the past 5 years, insiders at Tekla Life Sciences Investors have bought $2.9M and sold $5.31M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Saba Capital Management, L.P. (10 percent owner) — $195,880. DiMartino Rose (director) — $15,530. Maher Bill (director) — $9,991.
The last purchase of 650 shares for transaction amount of $9,991 was made by Maher Bill (director) on 2024‑08‑23.
| 2025-05-20 | Sale | Saba Capital Management, L.P. | 10 percent owner | 11,419 0.0395% | $12.71 | $145,135 | +0.68% | |
| 2025-05-15 | Sale | Saba Capital Management, L.P. | 10 percent owner | 23,729 0.082% | $12.08 | $286,646 | +4.64% | |
| 2025-05-14 | Sale | Saba Capital Management, L.P. | 10 percent owner | 600 0.0021% | $12.04 | $7,224 | +4.00% | |
| 2025-05-13 | Sale | Saba Capital Management, L.P. | 10 percent owner | 730 0.0026% | $12.28 | $8,964 | +2.70% | |
| 2025-05-08 | Sale | Saba Capital Management, L.P. | 10 percent owner | 12,689 0.0438% | $11.98 | $152,014 | +4.64% | |
| 2025-05-07 | Sale | Saba Capital Management, L.P. | 10 percent owner | 1,366 0.0048% | $12.19 | $16,652 | +3.01% | |
| 2025-04-17 | Sale | Saba Capital Management, L.P. | 10 percent owner | 9,144 0.0355% | $11.78 | $107,716 | +5.84% | |
| 2025-04-15 | Sale | Saba Capital Management, L.P. | 10 percent owner | 1,700 0.0067% | $11.92 | $20,264 | +6.33% | |
| 2025-04-14 | Sale | Saba Capital Management, L.P. | 10 percent owner | 15,400 0.0593% | $11.67 | $179,718 | +5.75% | |
| 2025-04-10 | Sale | Saba Capital Management, L.P. | 10 percent owner | 30,156 0.1109% | $11.14 | $335,938 | +12.03% | |
| 2025-04-04 | Sale | Saba Capital Management, L.P. | 10 percent owner | 6,889 0.0255% | $11.57 | $79,706 | +8.39% | |
| 2025-04-03 | Sale | Saba Capital Management, L.P. | 10 percent owner | 10,321 0.038% | $12.23 | $126,226 | +1.89% | |
| 2025-04-02 | Sale | Saba Capital Management, L.P. | 10 percent owner | 29,102 0.1061% | $12.28 | $357,373 | +0.57% | |
| 2025-04-01 | Sale | Saba Capital Management, L.P. | 10 percent owner | 17,621 0.065% | $12.45 | $219,381 | +0.08% | |
| 2025-03-31 | Sale | Saba Capital Management, L.P. | 10 percent owner | 48,623 0.1762% | $12.58 | $611,677 | -2.76% | |
| 2025-03-28 | Sale | Saba Capital Management, L.P. | 10 percent owner | 3,602 0.0132% | $12.95 | $46,646 | -4.04% | |
| 2025-03-27 | Sale | Saba Capital Management, L.P. | 10 percent owner | 32,922 0.1206% | $13.01 | $428,315 | -4.62% | |
| 2025-03-24 | Sale | Saba Capital Management, L.P. | 10 percent owner | 2,329 0.0085% | $13.21 | $30,766 | -6.45% | |
| 2025-02-26 | Sale | Saba Capital Management, L.P. | 10 percent owner | 200 0.0007% | $13.62 | $2,724 | -5.88% | |
| 2025-02-13 | Sale | Saba Capital Management, L.P. | 10 percent owner | 100 0.0004% | $13.88 | $1,388 | -5.85% |
| Saba Capital Management, L.P. | 10 percent owner | 3017539 10.4513% | $38.05M | 31 | 28 | +13.83% |
| Maher Bill | director | 1715 0.0059% | $21,628.84 | 2 | 0 | +11.39% |
| DiMartino Rose | director | 1000 0.0035% | $12,610.00 | 1 | 0 | |
| OMSTEAD DANIEL R | President | 197518 0.6841% | $2.49M | 17 | 0 | +15.48% |
| STEBBINS LUCINDA H | director | 5985 0.0207% | $75,472.99 | 4 | 1 | <0.0001% |
| LEWIN LAWRENCE S | director | 2920 0.0101% | $36,821.20 | 1 | 0 | +7.03% |
| REARDON WILLIAM S | director | 1612 0.0056% | $20,327.32 | 2 | 0 | +23.62% |
| Kent Thomas M | director | 1300 0.0045% | $16,393.00 | 1 | 0 | <0.0001% |
| Goetz Kathleen | director | 1085 0.0038% | $13,685.73 | 3 | 0 | +1.13% |
| Reit Todd | director | 1000 0.0035% | $12,610.00 | 1 | 0 | +9.86% |
| BONNEY MICHAEL W | director | 800 0.0028% | $10,088.00 | 1 | 0 | +17.72% |
| Bailey Jeffrey Allen | director | 580 0.002% | $7,313.80 | 1 | 0 | +20.39% |
| POHOTSKY OLEG M | director | 200 0.0007% | $2,522.00 | 1 | 0 | +17.93% |
$3,897,379 | 273 | 14.13% | $275.54M | |
$110,776,365 | 170 | 0.96% | $205.24M | |
$11,078,248 | 144 | 25.95% | $439.44M | |
$15,231,173 | 142 | 32.86% | $174.76M | |
$9,351,327 | 116 | 12.80% | $391.01M | |
$8,121,707 | 113 | 7.90% | $517.93M | |
$3,329,679 | 103 | 9.67% | $299.03M | |
$4,260,367 | 95 | 4.31% | $600.67M | |
$3,763,592 | 94 | 10.01% | $424.85M | |
$2,625,041 | 91 | 4.00% | $200.87M | |
$3,229,650 | 85 | 11.56% | $352M | |
$36,712,281 | 51 | 24.11% | $178.77M | |
$4,187,210 | 51 | 19.94% | $270.77M | |
$1,783,625 | 50 | 8.69% | $485.42M | |
Tekla Life Sciences Investors (HQL) | $9,014,091 | 50 | 12.31% | $364.08M |
$2,240,929 | 28 | 22.49% | $377.35M | |
$29,554,520 | 21 | -5.73% | $535.54M | |
$2,776,698 | 16 | 10.44% | $360.04M | |
$1,013,522 | 12 | 10.95% | $373.83M |
| Increased Positions | 50 | +73.53% | 854,361 | +8.89% |
| Decreased Positions | 26 | -38.24% | 1M | -14.98% |
| New Positions | 18 | New | 177,897 | New |
| Sold Out Positions | 7 | Sold Out | 572,393 | Sold Out |
| Total Postitions | 92 | +35.29% | 9M | -6.09% |
| Saba Capital Management, L.P. | $44,625.00 | 11.83% | 3.43M | +32 | +<0.01% | 2024-12-31 |
| Penserra Capital Management Llc | $9,717.00 | 2.58% | 746,921 | -80,654 | -9.75% | 2025-03-31 |
| Karpus Management, Inc. | $6,369.00 | 1.69% | 489,572 | +20,974 | +4.48% | 2024-12-31 |
| Sit Investment Associates Inc | $5,426.00 | 1.44% | 417,064 | 0 | 0% | 2024-12-31 |
| Morgan Stanley | $4,758.00 | 1.26% | 365,686 | -124,001 | -25.32% | 2024-12-31 |
| Needham Investment Management Llc | $4,589.00 | 1.22% | 352,719 | 0 | 0% | 2024-12-31 |
| Flagship Harbor Advisors, Llc | $4,435.00 | 1.18% | 340,877 | +90,436 | +36.11% | 2025-03-31 |
| Lpl Financial Llc | $3,735.00 | 0.99% | 287,095 | +129,313 | +81.96% | 2024-12-31 |
| 1607 Capital Partners, Llc | $3,215.00 | 0.85% | 247,147 | -102,354 | -29.29% | 2024-12-31 |
| Raymond James Financial Inc | $3,102.00 | 0.82% | 238,470 | +238,470 | New | 2024-12-31 |